ILUVIEN delivers proven efficacy

featured_man
  • ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg is an implant injected into the eye (vitreous) and is used for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a significant increase in eye pressure.

  • Based on the results of 2 clinical studies, ILUVIEN was proven to be safe and effective in the treatment of this condition as demonstrated for 24 months.

  • A single implant delivers the steroid for 36 months.

  • During the 3-year clinical trial, 75% of the people treated with ILUVIEN only had 1 ILUVIEN implant.

ILUVIEN may be an option for you even if you have been treated for DME before. You may not be a good candidate for ILUVIEN if you have been treated for increased pressure within the eye or glaucoma in the past.

Talk to your retina specialist for more information.





NEXT: See how ILUVIEN works. >>

See how ILUVIEN works

featured_man

ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg is a tiny implant that releases a low dose of a steroid called fluocinolone acetonide (FAc) to the retina. This helps treat the inflammation and edema associated with diabetic macular edema (DME).

In-office procedure

The ILUVIEN implant is injected into the eye with a custom inserter with a tiny needle, so there are no stitches needed.

symbol-36-months

The ILUVIEN implant begins to release low levels of steroid therapy to the retina in continuous, predictable amounts for 36 months.

how-does-it-work011

*Image shown is not actual size.





NEXT: What to expect with ILUVIEN. >>

In-office procedure

featured_man
calendar-icon

A single ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg implant is administered by a retina specialist during an in-office procedure. No surgery or hospital stay is typically required. And there are no stitches.

The injection procedure

Prior to the procedure, your eye is numbed. The ILUVIEN implant is then injected with a specialized inserter that has a tiny needle. As the implant is being injected, you may feel some pressure.

Discomfort afterwards

People who get injections in the eye can sometimes feel slight pressure in the eye afterwards. Intravitreal injections, including those with ILUVIEN, have been associated with serious eye infection (endophthalmitis), eye inflammation, increased eye pressure, and retinal detachments. Patients should be monitored following the intravitreal injection.

Tell your doctor

Tell your doctor immediately if the eye becomes red, sensitive to light, painful, or develops a change in vision.





NEXT: Learn about ILUVIEN safety. >>

Most common side effects and risks

featured_man

ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg releases a steroid in small, controlled doses. While every patient is different, your doctor may recommend ILUVIEN for you. ILUVIEN is a prescription medicine that is inserted in the eye and has its risks.

Talk to your doctor about the risks associated with ILUVIEN.

In clinical trials, the most common adverse reactions reported were the development of cataracts (ILUVIEN 82%; sham 50%) and increased eye pressure (ILUVIEN 34%; sham 10%).

If a cataract develops, your vision will decrease, and you will need an operation to remove the cataract and restore your vision.

If you experience a rise in pressure within the eye, the increase in pressure may need to be managed with eye drops or surgery.

In the days following the administration of ILUVIEN, you are at risk for potential complications including in particular, but not limited to, the development of endophthalmitis (an inflammation of the eye) and/or elevated pressure within the eye.

Talk to your doctor immediately if the eye becomes red, sensitive to light, painful, or develops a change in vision.

You may experience temporary visual blurring after receiving ILUVIEN. Do not drive or operate machinery until this blurriness has resolved.





NEXT: Get patient support for ILUVIEN. >>

Frequently Asked Questions

featured_man

ILUVIEN is a tiny implant designed to release a continuous, low dose of a steroid to the retina for 36 months. The medicine in ILUVIEN is called fluocinolone acetonide (FAc), a type of steroid called a corticosteroid. FAc helps treat the inflammation associated with diabetic macular edema (DME).

When DME develops, fluid collects in a part of the eye called the macula causing it to swell, which results in blurry vision. ILUVIEN is a corticosteroid used in the treatment of DME.

There are different types of steroids. Corticosteroids are man-made drugs that closely resemble cortisol, a hormone produced by the adrenal glands. Corticosteroids are different from the male hormone-related steroid compounds that some athletes abuse.

ILUVIEN is different from all other DME treatments because of the way it delivers drug. The tiny ILUVIEN implant is inserted into the eye and remains in the eye providing continuous drug delivery for 36 months. It is the only FDA-approved implant that delivers steroid for 36 months.

The most common risk related to ILUVIEN treatment is the formation of cataracts. If a cataract occurs, your vision will decrease and you will need cataract surgery to restore your vision.

Another risk of ILUVIEN is increased pressure within the eye, which may progress to glaucoma. This increase in pressure can be treated with eye pressure-lowering medicines (usually eye drops). However, some people may require eye surgery to treat their increased eye pressure.

Intravitreal injections, including those with ILUVIEN, have been associated with serious eye infection (endophthalmitis), eye inflammation, increased eye pressure, and retinal detachments. Patients should be monitored following the injection.

For additional safety information, please talk to your doctor and see the ILUVIEN full prescribing information.

ILUVIEN is administered by a retina specialist during an in-office procedure. No surgery or hospital stay is typically required. And there are no stitches.

Prior to the procedure, your eye is numbed. The ILUVIEN implant is then delivered via a tiny needle. As the implant is being injected, you may feel some pressure on your eye.

Your doctor will check your eye after the injection for possible side effects, including development of cataracts, eye infection (endophthalmitis), eye inflammation, increased eye pressure, glaucoma, and retinal detachments.

The number of treatments you receive will depend on your condition and on what your Retina Specialist thinks is best for you.

ILUVIEN is designed to release a continuous, low dose of a steroid to the retina for 36 months.

Do not use ILUVIEN if you have or think you might have an infection in or around the eye.

ILUVIEN should not be used if you have glaucoma.

ILUVIEN lasts for 36 months. However, your doctor will still want to see you periodically to monitor your condition and to monitor for development of cataracts, eye infection (endophthalmitis), eye inflammation, increased eye pressure, glaucoma, and retinal detachments.

It is important to make sure to keep your routine exams with your doctor. Committing to your eye health with ILUVIEN means keeping your appointments with your doctor.

For additional safety information, please talk to your doctor and see the ILUVIEN full prescribing information.

At Alimera Sciences, we believe all medicines should be accessible to the patients who need them, so we’ve created the ILUVIEN AccessPlus support program for patients with a financial need. The following support options are available:

  • ILUVIEN Co-pay Program – providing co-pay assistance for eligible, commercially insured patients
  • Co-pay Assistance Foundations – foundations provide co-pay assistance for insured patients
  • ILUVIEN Patient Assistance Program – ILUVIEN provided at no cost for qualified uninsured patients.
  • For more information click here or please call AccessPlus at 1.844.445.8843, Option 3.